Safe Harbor Financial Signs Non-Binding Term Sheet to Combine with Opifex Media, Creating a Nasdaq-Listed Diversified Holding Company
Existing Safe Harbor stakeholders would retain a minority stake before any closing financing and equity incentive reserve.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Safe Harbor Financial (SHFS) signed a non-binding term sheet to combine with Opifex Media in a proposed holding-company structure. Opifex would become a wholly owned subsidiary, adding creator-economy businesses alongside Safe Harbor’s continuing cannabis financial services business.
Opifex security holders would receive 85% of fully diluted ownership and existing Safe Harbor stakeholders 15%, before closing financing and an incentive reserve. Safe Harbor’s allocation could range from 12.5% to 17.5%, supported by a fairness opinion. The contemplated Opifex valuation is not less than $50 million, subject to independent review.
The parties intend to close before April 19, 2027, subject to definitive agreements, diligence, approvals and other conditions. Nasdaq extended Safe Harbor’s deadline to regain compliance with its $1.00 minimum bid price requirement through that date.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major point. Forward-looking: it has not happened yet and may not happen.Potential financing includes a direct investment of up to $1.0 million, subject to stockholder approval. 7.3× market cap
- Moderate point. Forward-looking: it has not happened yet and may not happen.Proposed Opifex combination would add creator-economy businesses while retaining Safe Harbor’s cannabis financial services operation.
- Moderate pointAdditional 180-day Nasdaq compliance period extends the bid-price compliance deadline through April 19, 2027.
- Minor point. Forward-looking: it has not happened yet and may not happen.Contingent value right intended for existing Safe Harbor stakeholders would relate to its cannabis financial services business.
- Minor point. Forward-looking: it has not happened yet and may not happen.CREO Capital equity line draws are not intended until the proposed transaction closes.
Negative
- Moderate point. Forward-looking: it has not happened yet and may not happen.Newly issued shares would give Opifex holders 85% ownership; existing Safe Harbor stakeholders would retain 15%, subject to adjustment.
- Moderate pointNon-binding term sheet leaves completion dependent on negotiating definitive agreements; exclusivity lasts 45 days.
- Moderate point$1.00 minimum bid price noncompliance remains unresolved; Safe Harbor would seek reverse-split approval if needed.
- Minor point. Forward-looking: it has not happened yet and may not happen.Safe Harbor’s allocation could range from 12.5% to 17.5%, before closing capital and any equity incentive reserve.
- Minor pointClosing dependencies include satisfactory diligence, Opifex audited financial statements, independent valuation and a fairness opinion.
4 minor points
- Minor pointRequired approvals include Safe Harbor stockholder and Nasdaq approval, alongside completion of any required financing.
- Minor pointSeries B conversion at closing requires holder agreements, consents and waivers.
- Minor point. Forward-looking: it has not happened yet and may not happen.Proposed equity incentive reserve would equal 10% of fully diluted shares, subject to stockholder approval.
- Minor point. Forward-looking: it has not happened yet and may not happen.Possible registered equity financing to unaffiliated investors could add shares beyond the stated ownership allocations.
News Explained
The proposed reserve could dilute holders, while Series B conversion and new capital still depend on closing conditions and approvals.
The signed term sheet remains non-binding; if the combination closes, the proposed equity plan would reserve
The parties contemplate a registered equity financing if needed and, separately, a direct investment of up to
The term sheet also contemplates all outstanding Series B preferred securities converting into common stock at closing, but that requires agreements with, and consents and waivers from, Series B holders.
Details
Market move: SHFS -10.05% vs previous close. proposed merger term sheet
On Oct 26, the day this news came out, the latest delayed price for SHFS is 10.05% below the previous close. Argus tracked a peak move of +26.6% during the session. Argus tracked a trough of -2.8% from its starting point during tracking. Our momentum scanner has recorded 85 alerts for this stock so far that day. The latest delayed price is $0.12. Relative volume is exceptionally heavy at 202.9x the average.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
- Ownership at closing
- 85% / 15%
- Opifex security holders / Safe Harbor stakeholders; before capital raised and equity plan reserve
- Safe Harbor ownership adjustment range
- 12.5%–17.5%
- May be adjusted based on Safe Harbor's closing valuation and an independent fairness opinion
- Contemplated Opifex valuation
- Not less than $50 million
- Subject to independent valuation and fairness opinion
- Potential direct investment
- Up to $1.0 million
- Subject to stockholder approval and intended to support Nasdaq listing requirements
- Equity incentive plan reserve
- 10% of fully diluted shares
- At closing; subject to stockholder approval
- Exclusivity period
- 45 days
- Term-sheet provision
- Target closing deadline
- Before April 19, 2027
- Proposed transaction timing
Historical Context
-
Nasdaq granted an additional 180-day bid-price compliance period ending April 19, 2027.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
contingent value right financial
reverse acquisition financial
fully diluted financial
fairness opinion financial
equity line of credit financial
reverse stock split financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Combined company would operate two distinct businesses under one parent: Opifex’s creator-economy platform and Safe Harbor’s established cannabis financial services business
Technology pioneer Greg Newman to serve as Chairman of the combined company
Transaction designed to support Safe Harbor’s plan to maintain its Nasdaq listing; Nasdaq has granted a second compliance period through April 19, 2027
DENVER, Oct. 26, 2026 (GLOBE NEWSWIRE) -- SHF Holdings, Inc., d/b/a Safe Harbor (“Safe Harbor” ) (Nasdaq: SHFS), a fintech platform serving the banking, lending and financial services needs of the regulated cannabis and hemp industries, announced that it has signed a non-binding term sheet with Opifex Media Inc. (“Opifex”), a Beverly Hills, California-based media holding company focused on the creator economy, for a proposed business combination in which Opifex would become a wholly owned subsidiary of Safe Harbor (the “Proposed Transaction”). Following the closing, the combined company would remain listed on The Nasdaq Stock Market LLC (“Nasdaq”) under a new name to be determined.
The Proposed Transaction is intended to create a public holding company with two distinct primary businesses, each pursuing its own growth strategy. Opifex would bring a portfolio of creator-economy businesses across publishing, music and video. Safe Harbor would continue to operate its cannabis-focused fintech platform and serve its clients and financial institution partners without interruption. For stockholders, the Proposed Transaction is designed to add a new growth platform, support Safe Harbor’s plan to maintain its Nasdaq listing, and create the opportunity for long-term value.
“Today’s announcement is an important step for Safe Harbor and our stockholders,” said Terry Mendez, Chief Executive Officer and Chief Financial Officer of Safe Harbor. “This proposed combination is intended to bring a growth-oriented creator-economy platform into our public company and to meet Nasdaq listing standards at closing. Greg Newman brings decades of experience building and scaling technology companies to the combined company’s board, and we believe this combination creates a compelling path forward for our stockholders.”
About Opifex and the Creator Economy Opportunity
Opifex acquires, operates and grows established creator-economy businesses across publishing, music and video, connecting them through a shared creator and data platform. The company focuses on verified human content and uses AI to improve operational efficiency, not to create content, while helping creators monetize through audiences, brands, subscriptions, licensing and media campaigns. By integrating these businesses, Opifex seeks to create a unified ecosystem that expands creator reach, strengthens first-party data and builds multiple revenue streams from the same creator-economy infrastructure.
According to Goldman Sachs Research, the creator economy was approximately
Opifex is led by Chairman Greg Newman. Mr. Newman is a serial entrepreneur and technology pioneer whose four-decade career spans foundational innovations in digital video and e-commerce, early backing of Baidu, and leadership of ventures shaping space power, the creator economy, sustainable energy and consumer technology. A former Fortune 500 executive and accomplished investor, Mr. Newman has helped build companies from the earliest days of the internet through major exits and global growth, while continuing to lead ambitious businesses at the forefront of innovation. His experience includes the founding team of Macromedia, leading QuickTime at Apple, building the Oracle Commerce Server, serving as an early institutional investor and board director of Baidu through its 2005 Nasdaq IPO, and co-founding C2B Technologies, which was acquired by Inktomi in 1998.
“The creator economy represents a significant opportunity to build a portfolio of complementary media businesses with established audiences and valuable intellectual property,” said Mr. Newman. “Our strategy is to acquire and grow platforms that serve creators, connect their audiences and create additional opportunities for monetization. We believe a combination with Safe Harbor provides the right public-company foundation for that vision, and we are committed to supporting the continued operation of Safe Harbor’s cannabis financial services business.”
Safe Harbor’s Cannabis Financial Services Business Continues
Safe Harbor will continue to operate its cannabis-focused fintech platform, delivering compliant banking, lending and business solutions to cannabis operators, as well as the infrastructure and compliance services financial institutions need to operate and scale cannabis banking programs. Since inception, Safe Harbor has supported the processing of more than
Key Terms of the Non-Binding Term Sheet
Structure. Opifex would merge with a newly formed, wholly owned subsidiary of Safe Harbor, and Opifex security holders would receive newly issued shares of Safe Harbor’s common stock, or, if the parties agree after consulting with Nasdaq, a combination of common stock and non-voting convertible preferred stock. The Proposed Transaction is expected to be accounted for as a reverse acquisition.
Ownership. At closing, Opifex security holders would own
Valuation. Opifex will deliver a proposed valuation, together with its financial statements and supporting analysis, within 15 business days. The term sheet contemplates an Opifex valuation of not less than
Contingent Value Right. The parties intend to negotiate a contingent value right for Safe Harbor’s existing stakeholders relating to Safe Harbor’s cannabis financial services business as part of the definitive agreements.
Equity Line of Credit. Safe Harbor does not intend to draw on its existing equity line of credit with CREO Capital until the closing of the Proposed Transaction.
Series B Preferred Securities. The term sheet contemplates the parties making arrangements under which all outstanding Series B Preferred Securities would convert into common stock at closing. These arrangements require entering into agreements with, and obtaining consents from, and waivers of Series B holders of transaction documents.
Capital and Nasdaq Listing. The parties intend for the combined company to meet applicable Nasdaq listing requirements at closing, including through a registered equity financing to investors who are not affiliates of either party, if necessary, and a direct investment of up to
Equity Incentive Plan. At closing, the combined company would adopt an equity incentive plan, subject to stockholder approval, with a reserve equal to
Governance. The combined company’s five-member board would include Mr. Newman as Chairman, one additional Opifex designee, two independent directors designated by Opifex and approved by Safe Harbor’s Nominating and Corporate Governance Committee, and one director from Safe Harbor. Opifex would designate the combined company’s officers.
Timing and Conditions. The parties intend to negotiate a definitive agreement and to close the Proposed Transaction before April 19, 2027. Closing would be subject to, among other things, the negotiation of a definitive agreement, satisfactory due diligence findings by both parties, the required consents and agreements with holders of the Series B Securities, the completion of Opifex’s audited financial statements, an independent valuation and fairness opinion, Safe Harbor stockholder approval, Nasdaq approval, completion of any required financing and other customary conditions. The term sheet includes a 45-day exclusivity period.
As previously announced, on October 20, 2026, Nasdaq granted Safe Harbor an additional 180-day compliance period, through April 19, 2027, to regain compliance with the
The independent members of the Board of Directors of Safe Harbor have approved entry into the term sheet. The term sheet is non-binding, except for certain customary provisions such as exclusivity and confidentiality, and does not obligate either party to complete the Proposed Transaction. There can be no assurance that a definitive agreement will be executed or that the Proposed Transaction will be completed on the terms described above or at all.
About Opifex Media
Opifex Media Inc. is a Beverly Hills, California-based holding company that acquires, operates and grows businesses across the creator economy, including publishing, music and video. www.opifexmedia.com
About Safe Harbor:
Safe Harbor is a cannabis-exclusive financial platform delivering smarter banking, lending, payments and business services tailored to how the cannabis industry actually operates. As one of the original pioneers of compliant financial operations support and cannabis banking consulting in the U.S., Safe Harbor has assisted in the processing of more than
Solicitation Material
This communication may be deemed to be solicitation material in connection with the proposals to be submitted to Safe Harbor’s stockholders at a meeting of stockholders seeking approval of certain matters in connection with the Proposed Transaction (the “Stockholder Meeting”). In connection with the proposals, Safe Harbor may file with the Securities and Exchange Commission (the “SEC”) a registration statement on Form S-4 (the “Registration Statement”), which will include a proxy statement of Safe Harbor and a prospectus (the “Proxy Statement/Prospectus”). After the Registration Statement is declared effective, Safe Harbor will mail the definitive Proxy Statement/Prospectus to its stockholders. INVESTORS AND SECURITY HOLDERS OF SAFE HARBOR ARE URGED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, AND ANY AMENDMENTS OR SUPPLEMENTS THERETO, CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT SAFE HARBOR, OPIFEX, THE PROPOSED TRANSACTION AND THE PROPOSALS. Investors and security holders may obtain free copies of the Registration Statement, the Proxy Statement/Prospectus and other documents that Safe Harbor files with the SEC, when available, at the SEC’s website (www.sec.gov) or from Safe Harbor by accessing information included on Safe Harbor’s website (ir.shfinancial.org), which is not incorporated by reference herein.
Participants in the Solicitation
Safe Harbor, Opifex and their respective directors and certain of their respective executive officers may be deemed participants in the solicitation of proxies from Safe Harbor’s stockholders in connection with the Proposed Transaction. Information about Safe Harbor’s directors and executive officers, including their ownership of Safe Harbor securities, appears in Safe Harbor’s proxy statement for its 2026 annual meeting of stockholders, filed with the SEC on May 8, 2026 (under the captions “Security Ownership of Certain Beneficial Owners and Management” and “Compensation Discussion and Analysis”), and in its Annual Report on Form 10-K filed with the SEC on April 15, 2026. Changes in their holdings since those dates have been or will be reflected in Forms 3, 4, or 5 filed with the SEC. Information about Opifex’s directors and executive officers, and additional information about all participants and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the Proxy Statement/Prospectus and other relevant materials filed with the SEC when they become available. These documents can be obtained free of charge as described above.
No Offer or Solicitation
This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
Cautionary Statement Regarding Forward-Looking Statements:
Certain information contained in this press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included herein may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Forward-looking statements may include, but are not limited to, statements with respect to trends in the cannabis industry, including proposed changes in U.S. and state laws, rules, regulations and guidance relating to Safe Harbor’s services; Safe Harbor’s growth prospects and Safe Harbor’s market size; Safe Harbor’s projected financial and operational performance, including relative to its competitors and historical performance; success or viability of new product and service offerings Safe Harbor may introduce in the future; the impact volatility in the capital markets, which may adversely affect the price of Safe Harbor’s securities; the outcome of any legal proceedings that have been or may be brought by or against Safe Harbor; the execution of definitive agreements for the Proposed Transaction or the closing thereof; the Stockholder Meeting; and other statements regarding Safe Harbor’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “outlook,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would,” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including, without limitation: the occurrence of any event, change or other circumstances that could give rise to the termination of the term sheet or prevent the execution of any definitive agreements with respect to the Proposed Transaction; the inability to complete the Proposed Transaction due to the failure to obtain the required stockholder approvals or any other required agreements, approvals or consents, including the consent of the holders of the Series B Preferred Stock required under the Series B transaction documents; the inability to obtain the required financing to complete the Proposed Transaction or to satisfy other conditions to closing; changes to the proposed structure of the Proposed Transaction that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining any required approval of the Proposed Transaction; SHF’s ability to regain compliance with the Nasdaq minimum bid price requirement by April 19, 2027; dilution to SHF’s existing stockholders; Opifex’s ability to complete its pending acquisitions and deliver audited financial statements; and other risks and uncertainties described from time to time in Safe Harbor’s filings with the SEC. Safe Harbor undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.
Safe Harbor Investor Relations Contact:
ir@SHFinancial.org
Safe Harbor Media Relations Contact:
safeharbor@kcsa.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership would Safe Harbor SHFS stakeholders have after the proposed Opifex merger?
Existing Safe Harbor stakeholders would own 15% of the combined company on a fully diluted basis, before capital raised at closing and any equity incentive reserve. That allocation may be adjusted within 12.5% to 17.5% to reflect Safe Harbor’s closing valuation, supported by an independent fairness opinion.
When does Safe Harbor SHFS expect to close the Opifex combination?
The parties intend to close before April 19, 2027. Completion requires definitive agreements, satisfactory due diligence, required Series B holder arrangements, audited Opifex financial statements, independent valuation and a fairness opinion, stockholder and Nasdaq approvals, and any required financing.
How would the proposed Safe Harbor and Opifex combined company be governed?
The proposed five-member board would include Greg Newman as chairman, another Opifex designee, two independent directors designated by Opifex and approved by Safe Harbor’s nominating and governance committee, and one Safe Harbor director. Opifex would designate the combined company’s officers.
How would Safe Harbor pay Opifex security holders in the proposed combination?
Opifex security holders would receive newly issued Safe Harbor common stock, or a combination of common stock and non-voting convertible preferred stock if the parties agree after consulting Nasdaq. Opifex would merge with a newly formed Safe Harbor subsidiary, and the transaction is expected to be accounted for as a reverse acquisition.
When must Opifex provide valuation information for the proposed Safe Harbor combination?
Opifex must deliver a proposed valuation, financial statements and supporting analysis within 15 business days. The term sheet contemplates an Opifex valuation of not less than $50 million, subject to an independent valuation and fairness opinion delivered to Safe Harbor’s board.